Table 2 Major health challenge
From: A multicenter investigation of reablement in Norway: a clinical controlled trial
|  | The whole sample (N = 828) | Intervention-group (n = 707) | Control-group (n = 121) | |||
|---|---|---|---|---|---|---|
Major health challenge | n | % | n | % | n | % |
Fracture | 168 | 20.3 | 149 | 20.9 | 19 | 15.7 |
Dizziness/balance problems | 125 | 15.1 | 113 | 15.9 | 12 | 9.9 |
Pain | 82 | 9.9 | 70 | 9.8 | 12 | 9.9 |
Stroke | 75 | 9.1 | 66 | 9.3 | 9 | 7.4 |
Arthritis | 62 | 7.5 | 47 | 6.6 | 15 | 12.4 |
Heart disease | 49 | 5.9 | 37 | 5.2 | 12 | 9.9 |
Orthopedic disease | 37 | 4.5 | 29 | 4.1 | 8 | 6.6 |
Neurological disease other than stroke | 32 | 3.9 | 25 | 3.5 | 7 | 5.8 |
Pulmonary disease | 31 | 3.7 | 29 | 4.1 | 2 | 1.7 |
Back disease/problem | 20 | 2.4 | 17 | 2.4 | 3 | 2.5 |
Movement challenges/functional decline | 20 | 2.4 | 16 | 2.3 | 4 | 3.3 |
Sight problems/eye disease | 19 | 2.3 | 13 | 1.8 | 6 | 5.0 |
Cancer | 19 | 2.3 | 16 | 2.3 | 3 | 2.5 |
Mental health problems | 13 | 1.6 | 13 | 1.8 | – | – |
Amputation(s) | 12 | 1.5 | 11 | 1.5 | 1 | 0.8 |
Diabetes | 11 | 1.3 | 10 | 1.4 | 1 | 0.8 |
Digestion disease | 7 | 0.8 | 7 | 1.0 | – | – |
Urinary infection | 7 | 0.8 | 5 | 0.7 | 2 | 1.7 |
Sleep disease/problems | 3 | 0.4 | 3 | 0.4 | – | – |
Other health challengesa | 36 | 4.5 | 33 | 4.6 | 3 | 3.3 |
Number of additional health conditions mean (SD), min-max | 2 (2.06), 0–11 | 2 (2.04), 0–11 | 2 (2.17), 0–9 | |||